首页> 外文期刊>BMC Cancer >Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer
【24h】

Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer

机译:18F-FDG PET / CT在晚期上皮卵巢癌中检测到Supradphragmatic淋巴结转移的预后意义

获取原文
           

摘要

Supradiaphragmatic lymph node metastases (SdLNM) are frequently identified using 18F-FDG positron emission tomography/computed tomography (PET/CT) in advanced epithelial ovarian cancers (AEOC). This study aimed to determine the prognostic significance of SdLNM detected by PET/CT in patients with AEOC. Medical records of patients diagnosed with AEOC were retrospectively registered from January 2009 to July 2015. Patients were categorized according to PET/CT stage: PET/CT stage III, PET/CT stage IV with SdLNM, and PET/CT stage IV with other metastases. Clinicopathologic characteristics, recurrence patterns, survival outcomes were compared according to PET/CT stage. Anatomical distribution of SdLNM and effect of thoracic debulking surgery were estimated. A total of 295 patients were identified, including 176 patients who underwent primary debulking surgeries (PDS). Progression-free (P?=?0.671) and overall (P?=?0.525) survival did not differ significantly between patients with PET/CT IV with SdLNM and PET/CT IV with other metastases; however, patients with PET/CT IV with SdLNM had significantly poorer progression-free (P??0.001) and overall (P?=?0.016) survival than those with PET/CT stage III. Recurrence patterns were similar in all groups; intraperitoneal metastasis was the most common (78.8%) and thoracic recurrence alone accounted for less than 10%. Debulking of SdLNM lesions did not improve progression-free survival (P?=?0.425) or overall survival (P?=?0.465) of patients with AEOC. SdLNM detected using preoperative PET/CT are a negative prognostic factor in AEOC. Resection of suspicious SdLNM may not have effect to survival of patients with AEOC.
机译:在先进上皮细胞卵巢癌(AEOC)中,经常使用18F-FDG正电子发射断层扫描/计算断层扫描(PET / CT)来鉴定Supradphragmativatic淋巴结转移(SDLNM)。该研究旨在确定宠物/ CT检测到AEOC患者的SDLNM的预后意义。诊断为AEOC的患者的病程回顾性从2009年1月到2015年1月到7月。根据PET / CT阶段分类:PET / CT阶段III,PET / CT阶段IV与SDLNM,以及其他转移的PET / CT阶段IV。 。根据PET / CT阶段比较临床病理特征,复发模式,存活结果。估计了SDLNM的解剖学分布和胸泡渗透手术的影响。共鉴定了295名患者,其中包括176名患者接受初级剥离手术(PDS)。无进展(P?= 0.671)和总体(p?= 0.525)生存率在患有SDLNM和PET / CT IV的PET / CT IV与其他转移患者之间没有显着差异;然而,具有SDLNM的PET / CT IV的患者显着较差,无需(P?<0.001)和总体(P?= 0.016)生存,而不是PET / CT阶段III。所有群体中复发模式都相似;腹膜内转移是最常见的(78.8%),单独占胸部复发占少于10%。 SDLNM病变的剥离并未改善AEOC患者的无进展生存期(P?= 0.425)或整体存活(P?= 0.465)。使用术前PET / CT检测的SDLNM是AEC中的负预后因子。切除可疑SDLNM可能对AEOC患者的生存可能没有效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号